Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2025 Earnings Call Transcript February 12, 2026 Vertex Pharmaceuticals ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...

Produced from used motor oil through Vertex’s integrated collection network, the VTX-R6 supports applications requiring ...

Company distributes $7.7 million to employees for the most recent fiscal year Profit sharing is one of the many ways we ...

Jet Award Gala information complete with winners of the Jet Award, Legacy Award, Mr. Football and Jordan Larson Awards, ...

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today reported its financial and operating results for the full ...

SHENZHEN, GUANGDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- Walking through the neon-drenched streets of a ...

Moving beyond traditional swim strokes, 'Marie and the Blue Whale' introduces a 4-step mental safety protocol to ...

There I was, sitting in a mini cubicle in SecureNinja, the proctor facility where I chose to take my Program Management (PM) Practitioner Exam, ...

Rob’s Ranch, a leading men’s faith-based rehabilitation provider in Oklahoma, proudly announces a significant milestone ...